Salix Pharmaceuticals Competitors and Similar CompaniesClear all

Salix Pharmaceuticals's competitors and similar companies include Ipsen, Cipla, Vertex Pharmaceuticals and BioMarin Pharmaceutical.

	Salix Pharmaceuticals Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.	Ipsen Ipsen is a biopharmaceutical company.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
Founding Date	Founding Date 1988	Founding Date 1929	Founding Date 1935	Founding Date 1989	Founding Date 1997
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Bridgewater Township, US HQ	Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more
Employees	Employees 7481% decrease	Employees 5,358	Employees 27,764	Employees 5,40013% increase	Employees 3,0015% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 10.2 b	Valuation ($) N/A	Valuation ($) 121.4 b	Valuation ($) 13.3 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €3.7b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) $12b (FY, 2025)	Revenue (est.) $3.2b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods €659.1m (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)	Cost of goods $1.7b (FY, 2025)	Cost of goods $717.4m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit €3.3b (FY, 2025)	Gross profit ₹195b (FY, 2026)	Gross profit $10.4b (FY, 2025)	Gross profit $2.5b (FY, 2025)
Net income	Net income N/A	Net income €445.1m (FY, 2025)	Net income ₹38.7b (FY, 2026)	Net income N/A	Net income $348.9m (FY, 2025)
Operating ⚠
Products	Products N/A	Products N/A	Products 1.5 k (FY, 2024)	Products 6 (FY, 2022)	Products N/A